MedTrace Logo

Effectiveness of Yiqi Fumai Lyophilized Injection for Acute Heart Failure

NCT05586048 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2023-03-10

No results posted yet for this study

Summary

The goal of this cohort study is to observe the effectiveness of Yiqi Fumai Lyophilized Injection (YQFM) in patients with acute heart failure (AHF). It mainly aims to assess the effectiveness of YQFM on the 90-day mortality or readmission rate in patients with AHF and compare the results with AUGUST-AHF RCT study. There will be no intervention, but information will be collected during the hospital stay and during the follow-up period of 180 days . Researchers will compare exposed group(patients who received YQFM) and non-exposed group(patients who didn't received YQFM) to see if there is difference on the 90-day mortality or readmission rate.

Conditions

  • Acute Heart Failure
  • Complementary Medicine
  • Chinese Medicine

Interventions

DRUG

Yiqi Fumai Lyophilized Injection(YQFM)

No intervention was involved, but patients will be divided into exposed or non-exposed groups based on whether they received YQFM

Sponsors & Collaborators

  • National Natural Science Foundation of China

    collaborator OTHER_GOV

  • China Academy of Chinese Medical Sciences

    lead OTHER

Principal Investigators

  • Xuecheng Zhang, MD · Dongzhimen Hospital, Beijing

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2025-11-30
Completion
2025-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05586048 on ClinicalTrials.gov